FMR CORP 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Purchase |
2024-11-08 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 10,141,901 7.084% |
2,949,956 (+41.02%) |
Filing |
| 2024-08-16 1:18 pm Purchase |
2024-08-15 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 7,191,945 5.023% |
1,337,910 (+22.85%) |
Filing |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 5,854,035 4.310% |
-737,998 (-11.20%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 6,592,033 5.397% |
424,096 (+6.88%) |
Filing |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 6,167,937 5.143% |
379,133 (+6.55%) |
Filing |